Mario Sandoval

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.3K citations · Full text

Medicine, Oncology, Pharmacology +15

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara, Mustafa Özgüroğlu, Yung‐Jue Bang et al. · The Lancet · 2018 · 1.3K citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Oxidative Damage in Lymphocytes of Copper Smelter Workers Correlated to Higher Levels of Excreted Arsenic

Jorge Escobar, Lorena Varela‐Nallar, Claudio Coddou et al. · Mediators of Inflammation · 2010 · 29 citations · Full text

Pharmacy, Immunology, Toxicology +16

The kidney transplant experience at Hospital de Especialidades, Centro Médico Nacional de Occidente, IMSS, Guadalajara México.

Francisco Monteón, Benjamín Gómez, Carlos Valdespino et al. · PubMed · 2003 · 26 citations

Medicine, Infectious Diseases, Surgery +13

Early Steroid Withdrawal in Recipients of a Kidney Transplant From a Living Donor: Experience of a Single Mexican Center

Jorge Andrade‐Sierra, Enrique Rojas–Campos, Ernesto Germán Cardona-Muñóz et al. · Transplantation Proceedings · 2016 · 14 citations

Medicine, Nephrology, Surgery +16